Home › Therapeutic areas › Respiratory › COPD
COPD (4 companies)
Companies with an active program in COPD.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| APGE | Apogee Therapeutics | DermatologyGI/Hepatology+1 Rare | 1 | Phase 2 | — | 9 |
| CNTB | Connect Biopharma | Respiratory | 2 | Phase 2 | $45.9M | 4 |
| LQDA | Liquidia | CardiovascularImmunology+1 Rare | 1 | Approved | $3.97B | 9 |
| ZYME | Zymeworks | OncologyRespiratory | 1 | Approved | $2.10B | 11 |
No companies match.